Back | Next |
home / stock / mynz / mynz message board
Subject | By | Source | When |
---|---|---|---|
Time for this to show some returns | pumpnass | investorshub | 04/23/2023 9:34:54 AM |
$MYNZ bears are running | BlazingStocks | investorshub | 04/23/2023 5:39:01 AM |
Good read | l2 hunter | investorshub | 04/23/2023 12:38:40 AM |
Price gaining last trade up | budfoxfun | investorshub | 04/22/2023 9:46:54 PM |
$MYNZ should we be shorting? | pumpnass | investorshub | 04/22/2023 9:27:31 PM |
$MYNZ short squeeze all day | budfoxfun | investorshub | 04/22/2023 5:59:12 PM |
MomentumIts gaining last up | BlazingStocks | investorshub | 04/22/2023 5:31:14 PM |
$MYNZ is it bear time? Or do we go bull? | pumpnass | investorshub | 04/22/2023 5:17:38 PM |
The gaining up | BlazingStocks | investorshub | 04/22/2023 2:17:23 PM |
The gaining up | BlazingStocks | investorshub | 04/22/2023 12:01:05 PM |
Price gaining | budfoxfun | investorshub | 04/22/2023 9:44:49 AM |
The trading | budfoxfun | investorshub | 04/22/2023 3:21:36 AM |
best news of the day | BlazingStocks | investorshub | 04/21/2023 9:42:49 PM |
$MYNZ The gaining | pumpnass | investorshub | 04/21/2023 8:52:32 PM |
The gaining last trade up | budfoxfun | investorshub | 04/21/2023 8:01:05 PM |
Price gaining last up | budfoxfun | investorshub | 04/21/2023 5:24:57 PM |
$MYNZ Thoughts on where this is headed? | BlazingStocks | investorshub | 04/21/2023 4:39:00 PM |
should we be shorting? | BlazingStocks | investorshub | 04/21/2023 4:32:29 PM |
$MYNZ short squeeze all day | BlazingStocks | investorshub | 04/21/2023 1:33:03 PM |
MomentumIts now | budfoxfun | investorshub | 04/21/2023 12:43:35 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Mainz BioMed CEO Guido Baechler joined Steve Darling from Proactive to announce the company has submitted an application to the U.S. Food and Drug Administration requesting Breakthrough Device Designation for its innovative non-invasive Next Generation colorectal cancer sc...
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration study ReconAAsense A recent clinical analysis of this new configuration demonstrates sens...
BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and provided a cor...